J Korean Assoc Oral Maxillofac Surg.  2018 Oct;44(5):232-236. 10.5125/jkaoms.2018.44.5.232.

Comparison of temporomandibular disorders between menopausal and non-menopausal women

Affiliations
  • 1Department of Prosthodontics, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran. taghvam@yahoo.com
  • 2Postgraduate Student of Orthodontics, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.

Abstract


OBJECTIVES
Hormonal changes during menopause alter a woman's susceptibility to some disorders. Information regarding the prevalence of temporomandibular disorder (TMD) in menopausal women is limited in the literature. In this study, the prevalence and severity of TMDs were compared between menopausal and non-menopausal women.
MATERIALS AND METHODS
The study included 140 women (69 premenopausal and 71 postmenopausal) 45 to 55 years of age that were examined in Shiraz Dental School, Shiraz in Iran. The Helkimo clinical dysfunction index (Di) was used to evaluate temporomandibular joint (TMJ) dysfunction. The data were analyzed using chi-square and Fisher's exact tests.
RESULTS
Occurrence of TMD was significantly higher in menopausal than non-menopausal women (P < 0.001). All the TMD criteria based on Helkimo Di except range of mandibular movement were significantly more common in menopausal women. The range of mandibular movement was not significantly different between menopausal and non-menopausal women (P=0.178).
CONCLUSION
The results from this study show that TMD can be considered more common and severe in menopausal than non-menopausal women. This finding indicates that, similar to other conditions in menopausal women such as arthritis and osteoporosis, TMD should be taken into consideration by dental and medical professionals.

Keyword

Temporomandibular joint disorders; Menopause; Prevalence

MeSH Terms

Arthritis
Female
Humans
Iran
Menopause
Osteoporosis
Prevalence
Schools, Dental
Temporomandibular Joint
Temporomandibular Joint Disorders*

Reference

1. Okeson JP. Management of temporomandibular disorders and occlusion. St. Louis: Mosby Elsevier;2013. p. 129.
2. Ebrahimi M, Dashti H, Mehrabkhani M, Arghavani M, Daneshvar-Mozafari A. Temporomandibular disorders and related factors in a group of Iranian adolescents: a cross-sectional survey. J Dent Res Dent Clin Dent Prospects. 2011; 5:123–127.
3. De Leeuw R. [Orofacial pain: guidelines for assessment, diagnosis, and management]. 4th ed. São Paulo: Quintessence;2010. Portuguese.
4. Carlsson G, LeResche L. Epidemiology of temporomandibular disorders. In : Sessle B, Bryant P, Dionne R, editors. Progress in pain research and management. Seattle: International Association for the Study of Pain;1995. p. 211–226.
5. Poveda-Roda R, Bagán JV, Díaz-Fernández JM, Hernández-Bazán S, Jimenez-Soriano Y. Review of temporomandibular joint pathology. Part I: classification, epidemiology and risk factors. Med Oral Patol Oral Cir Bucal. 2007; 12:E292–E298.
6. Sari S, Sonmez H. Investigation of the relationship between oral parafunctions and temporomandibular joint dysfunction in Turkish children with mixed and permanent dentition. J Oral Rehabil. 2002; 29:108–112.
Article
7. Winocur E, Littner D, Adams I, Gavish A. Oral habits and their association with signs and symptoms of temporomandibular disorders in adolescents: a gender comparison. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 102:482–487.
Article
8. Emodi-Perlman A, Eli I, Friedman-Rubin P, Goldsmith C, Reiter S, Winocur E. Bruxism, oral parafunctions, anamnestic and clinical findings of temporomandibular disorders in children. J Oral Rehabil. 2012; 39:126–135.
Article
9. Clark GT. Etiologic theory and the prevention of temporomandibular disorders. Adv Dent Res. 1991; 5:60–66.
Article
10. Huang GJ, LeResche L, Critchlow CW, Martin MD, Drangsholt MT. Risk factors for diagnostic subgroups of painful temporomandibular disorders (TMD). J Dent Res. 2002; 81:284–288.
Article
11. Abubaker AO, Raslan WF, Sotereanos G. Estrogen and progester-one receptors in temporomandibular joint disc of symptomatic and asymptomatic persons: a preliminary study. J Oral Maxillofac Surg. 1993; 51:1096–1100.
12. Madani AS, Shamsian AA, Hedayati-Moghaddam MR, Fathi-Moghadam F, Sabooni MR, Mirmortazavi A, et al. A cross-sectional study of the relationship between serum sexual hormone levels and internal derangement of temporomandibular joint. J Oral Rehabil. 2013; 40:569–573.
Article
13. Abubaker AO, Hebda PC, Gunsolley JN. Effects of sex hormones on protein and collagen content of the temporomandibular joint disc of the rat. J Oral Maxillofac Surg. 1996; 54:721–727.
Article
14. Okuda T, Yasuoka T, Nakashima M, Oka N. The effect of ovariectomy on the temporomandibular joints of growing rats. J Oral Maxillofac Surg. 1996; 54:1201–1210.
Article
15. Yasuoka T, Nakashima M, Okuda T, Tatematsu N. Effect of estrogen replacement on temporomandibular joint remodeling in ovariectomized rats. J Oral Maxillofac Surg. 2000; 58:189–196.
Article
16. Landi N, Manfredini D, Lombardi I, Casarosa E, Boseo M. 17-beta estradiol and progesterone serum levels in temporomandibular disorder patients. Minerva Stomatol. 2004; 53:651–660.
17. Smith YR, Stohler CS, Nichols TE, Bueller JA, Koeppe RA, Zubieta JK. Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. J Neurosci. 2006; 26:5777–5785.
Article
18. Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord. 1992; 6:301–355.
19. Fricton JR, Schiffman EL. Reliability of a craniomandibular. J Dent Res. 1986; 65:1359–1364.
20. Helkimo M. Studies on function and dysfunction of the masticatory system. IV. Age and sex distribution of symptoms of dysfunction of the masticatory system in Lapps in the north of Finland. Acta Odontol Scand. 1974; 32:255–267.
21. Dosi R, Bhatt N, Shah P, Patell R. Cardiovascular disease and menopause. J Clin Diagn Res. 2014; 8:62–64.
22. Jamshed N, Ozair FF, Aggarwal P, Ekka M. Alzheimer disease in post-menopausal women: intervene in the critical window period. J Midlife Health. 2014; 5:38–40.
Article
23. Bay-Jensen AC, Slagboom E, Chen-An P, Alexandersen P, Qvist P, Christiansen C, et al. Role of hormones in cartilage and joint metabolism: understanding an unhealthy metabolic phenotype in osteoarthritis. Menopause. 2013; 20:578–586.
24. Macovei L, Ancuţa C, Belibou C, Chirieac R. [Bone mineral density in patients with rheumatoid arthritis]. Rev Med Chir Soc Med Nat Iasi. 2011; 115:723–730. Romanian.
25. LeResche L, Mancl L, Sherman JJ, Gandara B, Dworkin SF. Changes in temporomandibular pain and other symptoms across the menstrual cycle. Pain. 2003; 106:253–261.
Article
26. Haskin CL, Milam SB, Cameron IL. Pathogenesis of degenerative joint disease in the human temporomandibular joint. Crit Rev Oral Biol Med. 1995; 6:248–277.
Article
27. Fischer L, Torres-Chavez KE, Clemente-Napimoga JT, Jorge D, Arsati F, de Arruda, et al. The influence of sex and ovarian hormones on temporomandibular joint nociception in rats. J Pain. 2008; 9:630–638.
Article
28. Torres-Chávez KE, Sanfins JM, Clemente-Napimoga JT, Pelegrini-Da-Silva A, Parada CA, Fischer L, et al. Effect of gonadal steroid hormones on formalin-induced temporomandibular joint inflammation. Eur J Pain. 2012; 16:204–216.
Article
29. Yun KI, Chae CH, Lee CW. Effect of estrogen on the expression of cytokines of the temporomandibular joint cartilage cells of the mouse. J Oral Maxillofac Surg. 2008; 66:882–887.
Article
30. Flake NM, Hermanstyne TO, Gold MS. Testosterone and estrogen have opposing actions on inflammation-induced plasma extravasation in the rat temporomandibular joint. Am J Physiol Regul Integr Comp Physiol. 2006; 291:R343–R348.
Article
31. Craft RM. Modulation of pain by estrogens. Pain. 2007; 132:Suppl 1. S3–S12.
Article
32. LeResche L, Saunders K, Von Korff MR, Barlow W, Dworkin SF. Use of exogenous hormones and risk of temporomandibular disorder pain. Pain. 1997; 69:153–160.
Article
33. Nekora-Azak A, Evlioglu G, Ceyhan A, Keskin H, Berkman S, Issever H. Estrogen replacement therapy among postmenopausal women and its effects on signs and symptoms of temporomandibular disorders. Cranio. 2008; 26:211–215.
Article
34. Wu YW, Kou XX, Bi RY, Xu W, Wang KW, Gan YH, et al. Hippocampal nerve growth factor potentiated by 17β-estradiol and involved in allodynia of inflamed TMJ in rat. J Pain. 2012; 13:555–563.
Article
Full Text Links
  • JKAOMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr